Invivogen established in 1997 by scientists with a background in microbiology offers technical and creative excellence with its products. Proficiency in microbial fermentation allows for a large catalogue of biological molecules such as ultra-pure antibiotics, cutting edge mycoplasma treatments and so on. Invivogen possesses proficient chemistry and molecular biology professions who synthesize molecules and plasmids for research use and for studies which relate to gene therapy and vaccination. Furthermore, their study of innate immune receptor signaling pathways has led to the collection of reporter cell lines which are used for quality control and research and development.